Security key
48115J109
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 1,341,390
- Share change
- -795,643
- Total reported value
- $7,982,763
- Price per share
- $5.76
- Number of holders
- 34
- Value change
- -$492,957
- Number of buys
- 27
- Number of sells
- 7
Report period
Q4 2023
Institutions
34
Top holders
10
DERM full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
576,100
|
$1,578,514 | — | 30 Sep 2023 | |
| BRC Group Holdings, Inc. |
13F
|
Company |
2%
|
429,595
|
$1,177,090 | — | 30 Sep 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.6%
|
348,663
|
$955,337 | — | 30 Sep 2023 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
224,295
|
$615,000 | — | 30 Sep 2023 | |
| AMERICAN FINANCIAL GROUP INC |
13F
|
Company |
0.84%
|
180,000
|
$493,000 | — | 30 Sep 2023 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.52%
|
110,554
|
$302,918 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.34%
|
72,667
|
$199,108 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
69,509
|
$190,515 | — | 30 Sep 2023 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.11%
|
23,020
|
$63,075 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
20,900
|
$57,000 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
14,462
|
$39,626 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
14,392
|
$39,434 | — | 30 Sep 2023 | |
| Creative Planning |
13F
|
Company |
0.06%
|
13,764
|
$37,713 | — | 30 Sep 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.06%
|
12,244
|
$33,549 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
11,853
|
$32,477 | — | 30 Sep 2023 | |
| Allegiance Financial Group Advisory Services LLC |
13F
|
Company |
0.05%
|
10,000
|
$27,400 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,730
|
$4,740 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,455
|
$3,987 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
56
|
$153 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
7
|
$19 | — | 30 Sep 2023 | |
| Fortress Biotech, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,860,467
|
$11,735,820 | — | 12 May 2022 | |
| Ernest Robert de Paolantonio |
3/4/5
|
Officer |
—
class O/S missing
|
259,907
|
$1,356,715 | — | 04 Oct 2022 | |
| Jeffrey Paley |
3/4/5
|
Director |
—
class O/S missing
|
70,727
|
$369,195 | — | 28 Nov 2023 |
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2023
As of 31 Dec 2023,
Journey Medical Corp - Common Stock (DERM) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,341,390 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, VANGUARD GROUP INC, EAM Investors, LLC, NEUBERGER BERMAN GROUP LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., NewEdge Advisors, LLC, and PERKINS CAPITAL MANAGEMENT INC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
20
Q4 2023 holders
34
Holder diff
14
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.